We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
FDA inspectors found extensive cleanliness and sterility issues during visits to California Pharmacy and Compounding Center in Newport Beach, Calif., in March and April. Read More
Ohio’s attorney general filed a lawsuit against Purdue Pharma, Endo Health Solutions, Teva, Johnson & Johnson and Allergan this week, alleging they contributed to the opioid epidemic through fraudulent advertising. Read More
The Supreme Court’s ruling this week on a patent dispute over printer toner cartridges could have wider effects on the pharmaceutical industry, international sales and product reimportation. Read More
The FDA approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit hyperactivity disorder in pediatric and adult patients, including multiple strengths manufactured by Apotex, Teva, Aurobindo Pharma and Glenmark Pharmaceuticals. Read More